Human V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Protein

Product Graph
312€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx694099
tested applications
SDS-PAGE

Description

Human V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Host
HEK293 cells
Origin
Human
Observed MW
Molecular Weight: Calculated MW: 26.8 kDa  Observed MW (SDS-PAGE): 43-48 kDa

Sequence Fragment: Phe29-Ala258

Tag: C-terminal His tag
Expression
Recombinant
Purity
>95% (SDS-PAGE)
Size 1
20 µg
Size 2
100 µg
Form
Lyophilized Reconstitute in sterile H2O. Do not vortex.
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 5% - 8% Trehalose, Mannitol and 0.01% Tween-80.
Availability
Shipped within 5-15 working days.
Storage
Store lyophilized between -20 °C and -80 °C.
Dry Ice
No
UniProt ID
Q7Z7D3
Background
Protein VTCN1
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH1214

Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit

Ver Producto
FNab09461

VTCN1 antibody

Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.

Ver Producto
P1973

Recombinant Human VTCN1

Ver Producto